ADDvise signs Letter of Intent to acquire X-Ray Cassette Repair Company Inc.

14-02-2023   Regulatory press release

ADDvise Group has signed a Letter of Intent with the shareholder of X-Ray Cassette Repair Company Inc (”Reina Imaging”) regarding an acquisition of all shares in Reina Imaging.

Reina Imaging is an international medtech equipment manufacturer based in Crystal Lake, Illinois, USA. The company produces digital x-ray panel holders and related imaging products primarily for the healthcare industry. Reina Imaging is a supplier and product development partner to some of the world’s largest x-ray imaging companies. The company has a strong market position for customized x-ray panel protection devices and is the largest x-ray grid distributor in North America. The company’s customized and application-specific designs are well known throughout the imaging industry.

The company’s revenue for the full year 2022 amounted to USD 9.12 million, with an adjusted EBITDA of USD 1.92 million, corresponding to an adjusted EBITDA margin of 21.1 percent.

The purchase price for Reina Imaging amounts to a total of USD 14.75 million, divided into an initial payment of USD 10.75 million, and two potential earn-outs of maximum USD 4 million in total. To reach full earn-outs, Reina Imaging must reach an EBITDA of USD 2.11 million during the next twelve months after completion of the acquisition and an EBITDA of USD 2.33 million for the following twelve months.

The acquisition will be financed with own funds. ADDvise assesses that the acquisition will have a positive impact on ADDvise earnings per share during the financial year 2023.

The acquisition is subject to a due diligence and that the parties agree to enter into a share purchase agreement. The share purchase agreement and completion of the acquisition is scheduled to be completed during Q2, 2023.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

Important information

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on February 14, 2023, at 08:10 CET.


About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business - both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB, +46 8 503 015 50,,is the Company's Certified Adviser. Additional information is available at


Latest press releases

Year-end report 2022, January 1-December 31


October–December 2022 Net revenue for the period was SEK 320.3 million (155.0), an increase of 106.6 %. Organic growth was 5.5 %. Orders received for the period was SEK 517.7 million (177.6), an increase of 191.5 %. Organic growth was 7.7 %. Adjusted EBITDA for the period was SEK 85.8 million (19.0) EBITDA for the…

ADDvise presents financial targets for 2023


The Board of Directors of ADDvise Group has adopted financial targets for the financial year 2023: -          Net sales pro forma rolling 12 months shall by the end of the year reach SEK 1.6 billion. -          EBITDA pro forma rolling 12 months shall by the end of the year reach SEK 330 million. The below…

ADDvise signs Letter of Intent to acquire Diabetic Supplies Inc.


ADDvise Group has signed a Letter of Intent with the shareholder of Diabetic Supplies Inc. (”Diabetic Supplies” or the “Company”) regarding an acquisition of all shares in Diabetic Supplies. Diabetic Supplies is based in Columbus, Ohio, USA and is a distributor of medical devices for diabetic patients. The Company distributes, among other things, continuous glucose…